Galmed Pharmaceuticals

GLMDNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.625 M

$0.60 +0.48%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$10.3M

Loss-making

Shares outstanding

6,581,390

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#471Silo PharmaSILO$4.68M
#472Jaguar HealthJAGX$4.67M
#473Galmed PharmaceuticalsGLMD$4.63M
#474Mustang BioMBIO$4.55M
#475Revelation BiosciencesREVB$4.46M

Where these numbers come from

Share counts and financials for Galmed Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.